Showing 1 - 20 results of 28,773 for search '(( significant change points ) OR ( significant ((sizes decrease) OR (mean decrease)) ))', query time: 0.90s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

    Published 2025
    “…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”
  5. 5

    Multi-organ differential gene expression changes statistically significant at hypertension onset. by Eden Hornung (20148295)

    Published 2024
    “…<i>Tgfb1</i> is significantly decreased in male SHR kidney compared to female at 16 weeks of age (p = 0.004). …”
  6. 6
  7. 7
  8. 8

    Taxonomic changes grouped by phylum and direction of change in relative abundance that were significantly different in either time point comparison by PERMANOVA analysis. by Starin McKeen (12566057)

    Published 2022
    “…Log2 fold change (Log2FC) between mean relative abundances at each time point are colored in orange for increasing fold change, and blue for decreasing fold change. …”
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    No significant changes in lymphocyte frequencies in the mandibular and deep cervical LNs following cervical SCI. by Antigona Ulndreaj (9585088)

    Published 2020
    “…Differences between the sham and cervical SCI group at each time point were assessed by Mann-Whitney tests, whereas time-dependent changes within each injury group were assessed by one-way ANOVA (sham) and Kruskal Wallis (cervical SCI) with Bonferroni or Mann-Whitney post-hoc tests respectively. * <i>p</i> < 0.05, ** <i>p</i> ≤ 0.01 (indicated <i>p</i> represent values from post-hoc tests), <i>N</i> = 5–7 (2 weeks); 4 (10 weeks); 4 (20 weeks) rats/ injury group, mean ± SEM.…”
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Supplementary Material for: Longitudinal Decrease in Left Ventricular Size with Age: Impact on Mortality and Cardiovascular Hospitalization by figshare admin karger (2628495)

    Published 2025
    “…Participants were categorized by LVEDD change from baseline: No Change (<5 mm), Decreased (≥5 mm), and Increased (≥5 mm). Results: A decrease in LVEDD was observed in 24% of participants (mean change -9±3 mm) and was significantly associated with older age, female sex, decreased volumes, concentric remodeling and diastolic dysfunction. …”
  20. 20